Mouse Renal Adenocarcinoma Macrobeads Implantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mouse Renal Adenocarcinoma Macrobeads Implantation, covering 2018-10-17 to 2018-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T [Phase 2]